1. Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.
- Author
-
Ling D, Li H, Xi W, Wang Z, Bednarkiewicz A, Dibaba ST, Shi L, and Sun L
- Subjects
- Antibiotics, Antineoplastic chemistry, Antimetabolites, Antineoplastic chemistry, Cell Proliferation drug effects, Cell Survival drug effects, Doxorubicin chemistry, Drug Carriers chemistry, Drug Screening Assays, Antitumor, Fluorouracil chemistry, HeLa Cells, Humans, Hydrogen-Ion Concentration, Particle Size, Surface Properties, Antibiotics, Antineoplastic pharmacology, Antimetabolites, Antineoplastic pharmacology, Doxorubicin pharmacology, Drug Delivery Systems, Fluorouracil pharmacology, Metal-Organic Frameworks chemistry, Nanoparticles chemistry
- Abstract
Developing multifunctional nanocomposites for a pH-responsive controlled dual-drug delivery is still a huge challenge. Herein, we report a gentle and simple method for growing metal-organic frameworks (MOFs) that can load two anticancer drugs, namely DOX and 5-FU (doxorubicin and 5-fluorouracil), on the surface of upconversion nanoparticles (UCNPs) by the reactions of Schiff bases and electrostatic adsorption. The resulting pH-responsive UCMOFs@D@5 nanosystem showed effective dual-drug release by the cleavage of chemical bonds and the disruption of the MOF structure under acidic conditions. Moreover, the final nanosystem UCMOFs@D@5 showed much higher cytotoxicity in comparison with UCMOFs@D and UCMOFs@5, which loaded only one kind of drug, respectively, after being incubated with human cervical cancer (HeLa) cells, indicating that Dox and 5-FU released from the final nanosystem had synergistic effects on cytotoxicity. Cellular uptake studies showed that UCMOFs@D@5 was well uptaken by HeLa cells and has potential for bioimaging applications in intracellular fluorescence imaging with high-contrast, and is beneficial for the intracellular localization of anti-cancer drugs. In addition, the nanosystem can be successfully applied in T
1 -weighted magnetic resonance imaging. Therefore, we developed a visualized tracking agent combined with MOFs to load two anticancer drugs to form a nanosystem for diagnosis and synergistic treatment, thus achieving the bioimaging and stimulation-responsive dual-drug release.- Published
- 2020
- Full Text
- View/download PDF